Literature DB >> 8663536

The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression.

M David1, G Zhou, R Pine, J E Dixon, A C Larner.   

Abstract

Interferons (IFNs) induce early response genes by stimulating Janus family (Jak) tyrosine kinases, leading to tyrosine phosphorylation of Stat (signal transducer and activator of transcription) proteins. Previous studies demonstrated that a protein-tyrosine phosphatase (PTP) is required for activation of the ISGF3 transcription complex by IFNalpha/beta, but the specific PTP responsible remained unidentified. We now show that the SH2 domain containing tyrosine phosphatase PTP1D (also designated as SHPTP2, SHPTP3, PTP2C, or Syp) is constitutively associated with the IFNalpha/beta receptor and becomes tyrosine-phosphorylated in response to ligand. Furthermore, transient expression of a phosphatase-inactive mutant or the COOH-terminal SH2 domain of PTP1D causes a dominant negative effect on IFNalpha/beta-induced early response gene expression. These results provide strong evidence that PTP1D functions as a positive regulator of the IFNalpha/beta-induced Jak/Stat signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663536     DOI: 10.1074/jbc.271.27.15862

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Molecular mechanisms in T helper phenotype development.

Authors:  J D Farrar; S H Ranganath; K M Murphy
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Regulation of neuregulin-mediated acetylcholine receptor synthesis by protein tyrosine phosphatase SHP2.

Authors:  M Tanowitz; J Si; D H Yu; G S Feng; L Mei
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

3.  Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway.

Authors:  Zhimei Du; Yuhong Shen; Wentian Yang; Ingrid Mecklenbrauker; Benjamin G Neel; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-06       Impact factor: 11.205

4.  Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase.

Authors:  M Takahashi-Tezuka; Y Yoshida; T Fukada; T Ohtani; Y Yamanaka; K Nishida; K Nakajima; M Hibi; T Hirano
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

5.  Tyrosine phosphatase SHP-2 dephosphorylates the platelet-derived growth factor receptor but enhances its downstream signalling.

Authors:  R Zhao; Z J Zhao
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

Review 6.  Leptin Involvement in Primary Brain and Pituitary Tumors: Therapeutic Potential, Prognostic Value, and Proposed Diagnostic Application.

Authors:  Christos Bikis; Theodora Tzanavari; Krystallenia I Alexandraki; Stamatios Theocharis
Journal:  Horm Cancer       Date:  2018-02-20       Impact factor: 3.869

7.  Inhibition of response to alpha interferon by Mycobacterium tuberculosis.

Authors:  Savita Prabhakar; Yaming Qiao; Yoshihiko Hoshino; Michael Weiden; Antony Canova; Elena Giacomini; Eliana Coccia; Richard Pine
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

8.  Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.

Authors:  H Kim; H Baumann
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 9.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

10.  The benzoxathiolone LYR-71 down-regulates interferon-gamma-inducible pro-inflammatory genes by uncoupling tyrosine phosphorylation of STAT-1 in macrophages.

Authors:  E-Y Chung; B-H Kim; I-J Lee; E Roh; S-J Oh; J-A Kwak; Y-R Lee; B Ahn; S-Y Nam; S-B Han; Y Kim
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.